Mackenzie Financial’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-18,635
Closed -$1.45M 935
2016
Q2
$1.45M Sell
18,635
-8,879
-32% -$633K 0.01% 514
2016
Q1
$1.51M Buy
27,514
+2,562
+10% +$140K 0.01% 413
2015
Q4
$1.54M Buy
24,952
+2,068
+9% +$130K 0.01% 457
2015
Q3
$1.44M Sell
22,884
-9,344
-29% -$667K 0.01% 469
2015
Q2
$2.35M Buy
32,228
+6,472
+25% +$468K 0.01% 405
2015
Q1
$1.68M Buy
25,756
+2,662
+12% +$177K 0.01% 455
2014
Q4
$1.5M Sell
23,094
-8,314
-26% -$535K 0.01% 471
2014
Q3
$1.89M Buy
31,408
+13,725
+78% +$897K 0.01% 409
2014
Q2
$1.23M Buy
17,683
+925
+6% +$60K 0.01% 482
2014
Q1
$1.1M Buy
16,758
+2,114
+14% +$138K 0.01% 482
2013
Q4
$907K Buy
14,644
+3,355
+30% +$194K ﹤0.01% 511
2013
Q3
$606K Sell
11,289
-995
-8% -$51.2K ﹤0.01% 552
2013
Q2
$561K Buy
+12,284
New +$532K ﹤0.01% 570

Other funds holding STJ

Mackenzie Financial's STJ Position: Q3 2016 in Review

Mackenzie Financial sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 18,635 shares — an estimated $1.45M sold.

Mackenzie Financial first reported a position in STJ in Q2 2013 and held it in 13 quarters. The position peaked at $2.35M in Q2 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Mackenzie Financial reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Mackenzie Financial sold 18,635 St Jude Medical shares in Q3 2016, an estimated $1.45M.
  • Mackenzie Financial first reported a position in St Jude Medical in Q2 2013 and held it in 13 quarters.
  • Mackenzie Financial's St Jude Medical position peaked at $2.35M in Q2 2015.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Mackenzie Financial's 13F filing for Q3 2016, filed 15 Nov 2016.